Results 101 to 110 of about 9,745 (169)

Markers of Type 2 Inflammation and Immunosenescence Are Upregulated in Localized Scleroderma. [PDF]

Int J Mol Sci
Khoury L, Prosty C, Ghazal S, Gabrielli S, Torok KS, Osman M, Martinez-Jaramillo E, Lefrançois P, Netchiporouk E.   +8 more
europepmc   +1 more source

Clinical and laboratory characterization of patients with localized scleroderma and response to UVA-1 phototherapy: In vivo and in vitro skin models. [PDF]

Photodermatol Photoimmunol Photomed, 2022
Tognetti L, Marrocco C, Carraro A, Guerrini G, Mariotti G, Cinotti E, Rubegni P.   +6 more
europepmc   +1 more source

Incidence, prevalence, and mortality of localized scleroderma in Quebec, Canada: a population-based study. [PDF]

Lancet Reg Health Am
Ghazal S, Muntyanu A, Aw K, Kaouache M, Khoury L, Piram M, McCuaig C, Chédeville G, Rahme E, Osman M, Schachter J, Bertrand J, Netchiporouk E.   +12 more
europepmc   +1 more source

The Anti-Fibrotic Effect of Cold Atmospheric Plasma on Localized Scleroderma In Vitro and In Vivo. [PDF]

Biomedicines, 2021
Arndt S, Unger P, Bosserhoff AK, Berneburg M, Karrer S.   +4 more
europepmc   +1 more source

Unique and shared transcriptomic signatures underlying localized scleroderma pathogenesis identified using interpretable machine learning. [PDF]

JCI Insight
Rosen AB, Sanyal A, Hutchins T, Werner G, Berkowitz JS, Tabib T, Lafyatis R, Jacobe H, Das J, Torok KS.   +9 more
europepmc   +1 more source

Evaluation of Thiol Disulfide, Ischemia Modified Albumin, and Prolidase Parameters in Patients with Localized Scleroderma. [PDF]

Dermatol Pract Concept
Akbaş A, Şen O, Kılınç F, Neşelioğlu S, Saraç GA, Aktaş A.   +5 more
europepmc   +1 more source

Advances in the Management of Localized Scleroderma: A Systematic Review of Laser Therapy and Injectable Filler Approaches. [PDF]

J Pers Med
Cassalia F, Federico S, Danese A, Franceschin L, Amato S, Gratteri F, Battilotti C, Caroppo F, Zappia E, Bennardo L, Belloni Fortina A, Nisticò SP.   +11 more
europepmc   +1 more source

National Registry for Childhood Onset Scleroderma I: Insights from the first 341 juvenile localized scleroderma patients. [PDF]

J Scleroderma Relat Disord
Branton SA, Stubbs LA, Havrilla HJ, Torok KS.   +3 more
europepmc   +1 more source

Evaluation of autologous fat grafting in the treatment of juvenile localized scleroderma with facial involvement. [PDF]

J Scleroderma Relat Disord
Sander L, Foeldvari I, Glaser D, Klotsche J, Stier R, Roldán JC.   +5 more
europepmc   +1 more source

Damage evaluation of craniofacial localized scleroderma using magnetic resonance imaging. [PDF]

Quant Imaging Med Surg
Ma X, Huang J, Xue H, Wang H, Wang T, Chen Y, Long X, Wang X.   +7 more
europepmc   +1 more source